adrenal cortical carcinoma

a·dre·nal cor·ti·cal car·ci·no·ma

a carcinoma arising in the adrenal cortex that may cause virilism or Cushing syndrome.
Farlex Partner Medical Dictionary © Farlex 2012

ad·re·nal cor·ti·cal car·ci·no·ma

(ă-drē'năl kōr'ti-kăl kahr'si-nō'mă)
A carcinoma arising in the cortex of the suprarenal gland that may cause virilism or Cushing syndrome.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012
References in periodicals archive ?
Adrenal malignancies such as metastases from extra-adrenal primary cancer, adrenal cortical carcinoma, and pheochromocytomas usually have substantial FDG uptake (Figure 6), whereas benign adrenal masses such as adrenal cysts and adenomas usually have low or negative FDG avidity (Figure 7).
Adrenal cortical carcinoma, pheochromocytoma, metastatic adenocarcinoma, or malignant melanoma should be distinguished from primary adrenal angiosarcoma (10).
CHICAGO -- Patients with adrenal cortical carcinoma (ACC) who opt for surgery are predicted to survive significantly longer than those who choose chemotherapy or radiation at all stages, according to a study presented at the annual meeting of the Endocrine Society.
Adrenal cortical carcinoma (ACC) is a rare tumour with a worldwide incidence of 2 per million people, and is responsible for 0.2% of all cancer deaths.
Except for the general contraindications of laparoscopic procedures (unacceptable cardiopulmonary risk, uncorrected coagulopathy, abdominal sepsis, and intestinal obstruction), the absolute contraindication of laparoscopic adrenal surgery is the suspicion of a large adrenal cortical carcinoma, since open procedures allow better vascular control [13].
Malignant tumors include adrenal cortical carcinoma, metastatic carcinoma, lymphoma, and sarcoma.
Adrenal cortical carcinoma (ACC) also needs to be considered, especially when there is involvement of the adrenal gland.
(15,16) Inhibin-expressing clear cell NETs can also mimic clear cell adrenal cortical carcinoma; thus, positivity for steroidogenic factor-1 along with other cortical differentiation markers (Melan-A, calretinin, and synaptophysin) can be used in this distinction.
ChRCC can be confused with clear cell renal cell carcinoma or oncocytoma and several non-renal tumours with overlapping features including hepatocellular carcinoma, adrenal cortical carcinoma, lung carcinoma, and oncocytic tumours of salivary gland and thyroid.
Thus it may be underrecognized and mistaken for other neoplasias showing a similar morphology, including renal cell carcinoma, adrenal cortical carcinoma, and paraganglioma [33].
Ordonez, "Ultrastructure of adrenal cortical carcinoma," Ultrastructural Pathology, vol.